Natera delivers robust revenue growth, raising 2026 guidance to $2.74–$2.82 billion, but remains unprofitable. Read more on NTRA stock here.
India Today on MSN
The trailer trap and forgetting art of surprise: How much is too much?
What makes a great movie trailer? Audiences, editors, filmmakers and trade experts discuss the fine balance between building curiosity and giving away too much.
I'm Larry Biegelsen, the Medical Device Analyst at Wells Fargo. Welcome to the final call in our 2026 MedTech Innovation Spotlight Series. I'm pleased to be joined by Inspire Medical's management team ...
Speaking at the first Supreme Court Bar Association National Conference in Bengaluru, Justice BV Nagarathna of the Supreme ...
So, you’ve been saving for a house. You have cut right down on expenses, with holidays and meals out feeling like distant ...
Metabolic dysfunction-associated steatotic liver disease (MASLD) progression involves the replacement of protective embryo-derived Kupffer cells (KCs) by inflammatory monocyte-derived macrophages ...
MedPage Today on MSN
The Truth About 'Looksmaxxing'
Dr. Mike addresses the online epidemic affecting teen boys ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results